Skip to main content
Un site web officiel de l’Union européenneUn site officiel de l’UE
European Commission logo
français français
CORDIS - Résultats de la recherche de l’UE
CORDIS
CORDIS Web 30th anniversary CORDIS Web 30th anniversary
Contenu archivé le 2024-05-24

The potential of oligonucleotide submicrob positively charged, emulsion ocular delivery system for age related macular degeneration

Objectif

Navigable wants to investigate co-operation possibilities between two well-reputed research institutes and some European Sum’s to form a consortium for the research development and marketing of a remedy to treat ARMD. Age-related Macular Degeneration, a common eye disorder, the leading cause of severe vision loss in people older than 50 years. The wet form is the most severe type of macular degeneration notwithstanding it affects only 10% of those with the diseases it accounts for 90% of the blindness caused by ARMD.Today about 400,000 new cases of wet ARMD occur each year in the USA and Europe. Products existing today can treat only 15% of the patients with this form. Navigable wants, on basis of its oligonucleotide and Ribosome submicronpositively charged emulsion delivery system, to form the above alliance to bring the fruit of the cooperation as a remedy to the market which will result in dramatically increase of the treatment of wet ARMD and thus enormously reducing this cause of blindness.

Champ scientifique (EuroSciVoc)

CORDIS classe les projets avec EuroSciVoc, une taxonomie multilingue des domaines scientifiques, grâce à un processus semi-automatique basé sur des techniques TLN.

Vous devez vous identifier ou vous inscrire pour utiliser cette fonction

Appel à propositions

Data not available

Régime de financement

EAW - Exploratory awards

Coordinateur

NOVAGALI PHARMA SA
Contribution de l’UE
Aucune donnée
Adresse
Rue Pierre Fontaine 1
91000 EVRY
France

Voir sur la carte

Coût total
Aucune donnée

Participants (1)